Enteric fever, commonly known as typhoid fever, is a systemic infection primarily caused by Salmonella Typhi and Salmonella Paratyphi A, B, and C. The disease presents a significant health challenge, particularly in areas with inadequate sanitation and poor access to clean drinking water. This article provides an in-depth guide to the effective management of enteric fever.
Salmonella Typhi and Paratyphi are the causative organisms of enteric fever. These bacteria are transmitted via the fecal-oral route, often through contaminated food or water. High-risk areas include South Asia, Africa, and parts of South America. Travelers to these regions are particularly at risk.
Patients typically present with high-grade fever, malaise, abdominal discomfort, and constipation or diarrhea. In severe cases, complications such as intestinal perforation, encephalopathy, or myocarditis may occur. Early diagnosis is critical to preventing these complications.
Diagnosis of enteric fever primarily involves blood culture, bone marrow culture, or stool culture. Serological tests like Widal test are also used, but they have lower sensitivity and specificity. Molecular methods, such as PCR, are increasingly being used for rapid and accurate diagnosis.
Antibiotic therapy is the cornerstone of treatment. Choice of antibiotic is guided by local susceptibility patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. In resistant cases, carbapenems may be considered. Supportive care includes hydration and antipyretics.
Preventive measures include safe food and water practices, improved sanitation, and vaccination. Two vaccines are currently available: the oral live-attenuated vaccine (Ty21a) and the injectable polysaccharide vaccine (ViCPS).
In conclusion, enteric fever remains a significant global health challenge. Effective management involves early diagnosis, appropriate antibiotic therapy, and preventive measures. Ongoing research into better diagnostic tools and more effective vaccines is crucial for controlling this disease.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation